3190 results for «622»
3190 results
Complex combined transcatheter interventions
18 Nov 2025 – From PCR London Valves 2025
This session addresses complex combined transcatheter interventions for multivalvular heart disease. It covers integrated transcatheter strategies for multiple valve pathologies, solutions for combined severe aortic stenosis and mitral regurgitation with heavy calcification, and approaches to concomitant atrial functional mitral and tricuspid regurgitation. The session also discusses...
Transcatheter tricuspid valve replacement: pioneering techniques and solutions for high-risk patients
18 Nov 2025 – From PCR London Valves 2025
This session explores advanced transcatheter tricuspid valve replacement techniques and outcomes. It features cases of TricValve dysfunction due to intrinsic regurgitation, pioneering 'chimney technique' implantation in complex patients, right heart remodeling post-intervention, and innovative solutions including percutaneous heterotopic bicaval valve implantation following pericardiectomy.
TAVI: complex vascular access - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session focuses on managing complex vascular access challenges in TAVI procedures. It includes case discussions on non-crossable aortic valve stenosis, transseptal TAVI for severe aortic regurgitation with porcelain aorta, and percutaneous implantation in patients with unconventional anatomy or conditions like shaggy syndrome. Strategies for severe...
TAVI: alternative access - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session addresses alternative access routes for TAVI in patients with challenging vascular anatomy. Topics include transapical valve-in-valve procedures complicated by severe aortic regurgitation, percutaneous TAVI via the brachiocephalic trunk, and strategies for managing hostile vascular anatomies. Solutions for scenarios where transfemoral TAVI is not feasible...
Transcatheter solutions for failed mitral TEER
18 Nov 2025 – From PCR London Valves 2025
This session presents innovative transcatheter solutions for managing failed mitral TEER procedures. It highlights advanced closure strategies for inter-clip mitral regurgitation, percutaneous approaches for recurrent mitral regurgitation, novel chordae tendineae replacement techniques, and potential bailout strategies including atrial flow regulation implantation for recurrent heart failure.
Imaging to the rescue
11 Dec 2025 – From GulfPCR-GIM 2025
This session highlighted the pivotal role of advanced intracoronary imaging techniques, particularly OCT, in complex case management such as in-stent restenosis and thrombus evaluation. Through real-world cases, it demonstrated how imaging complements physiology to guide therapeutic decisions, including the use of drug-coated balloons beyond native coronary...
Transcatheter tricuspid valve replacement - LIVE case
Recommended by PCR
15 May 2024 – From EuroPCR 2024
An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
